WO2005030958A1 - 酵素が固定されている支持体、印刷物、試薬キット、該支持体の製造法、酵素の保存法及び酵素の再生法 - Google Patents
酵素が固定されている支持体、印刷物、試薬キット、該支持体の製造法、酵素の保存法及び酵素の再生法 Download PDFInfo
- Publication number
- WO2005030958A1 WO2005030958A1 PCT/JP2004/014245 JP2004014245W WO2005030958A1 WO 2005030958 A1 WO2005030958 A1 WO 2005030958A1 JP 2004014245 W JP2004014245 W JP 2004014245W WO 2005030958 A1 WO2005030958 A1 WO 2005030958A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- enzyme
- support
- paper
- dna polymerase
- dna
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
- C12N11/12—Cellulose or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
Definitions
- the present invention relates to a support on which an enzyme is immobilized, a printed matter, a reagent kit, and a method for producing the support.
- Enzymes are proteins having catalytic activity, and contribute to the maintenance of life by controlling various biological reactions.
- Enzymes are unstable at room temperature when they contain water. Therefore, they are stored frozen or stored in liquid with stabilizers at temperatures below 20 ° C.
- PCR polymerase chain reaction
- DNA polymerase is usually stored in a buffer at a temperature of 20 ° C. For such storage, a freezer is required. When this enzyme is delivered from the supplier to the user, it is packed in a container such as styrofoam together with dry ice.
- An object of the present invention is to provide a simple method for storing an enzyme.
- the present inventors have found that the PCR reaction proceeds when the DNA polymerase is immobilized on a support in the state of being mixed with trehalose and stored, and then the PCR reaction proceeds. Reached.
- the gist of the present invention is as follows.
- the protective agent is selected from the group consisting of compounds having trehalose and derivatives thereof.
- the support according to (1) which is at least one compound.
- the support according to (6) further comprising a primer for amplifying a target nucleic acid in a nucleic acid amplification reaction using the DNA polymerase.
- a nucleic acid to be used in the nucleic acid amplification reaction using the DNA polymerase comprising:
- a printed matter comprising the support according to any one of (1) to (8).
- a reagent kit comprising the support according to any one of (1) to (8).
- the present invention also provides a method of storing an enzyme in a state of being fixed to a support as a mixture with a protective agent.
- the present invention provides a method of disposing the support according to the above (7) in a liquid
- Eluting a DNA polymerase and at least one selected from the group consisting of a nucleic acid to be type III, a primer for amplifying the nucleic acid, and a buffer for a nucleic acid amplification reaction is intended to provide a method for amplifying a nucleic acid, which comprises performing a nucleic acid amplification reaction using the DNA polymerase and a nucleic acid and / or a primer that becomes type II.
- the present invention provides a support on which an enzyme and a protective agent for the enzyme are immobilized.
- the enzyme may be any enzyme having some catalytic activity. Examples thereof include DNA polymerase, RNA polymerase, reverse transcriptase, RNase, restriction enzyme, methylase, modification enzyme, ligase, Examples include, but are not limited to, proteases, kinases, phosphatases, transfectases, glycosylases, topoisomerases, clonase, and the like.
- the protective agent may be any one that can protect the enzyme in drying power and can be stored stably, such as trehalose and its derivatives, polysaccharides, PEG, dextran, Ficol, dalycerol, and surfactants. , PVA and derivatives thereof. Of these, trehalose and its derivatives are effective.
- the protective agent may be a commercially available one, or may be one synthesized according to a known method.
- Trehalose is a non-reducing disaccharide in which two molecules of D-glucose are bonded in a 1, 1 bond, and has three types of bonding, ⁇ , ⁇ -, ⁇ , ⁇ -, ⁇ , ⁇ -. There are isomers.
- trehalose derivative examples include trehalose acid esters (eg, fatty acid esters such as lauric ester, oleic acid ester, linoleic acid ester, linolenic acid ester, stearic acid ester, palmitic acid ester, myristic acid ester, etc.).
- trehalose acid esters eg, fatty acid esters such as lauric ester, oleic acid ester, linoleic acid ester, linolenic acid ester, stearic acid ester, palmitic acid ester, myristic acid ester, etc.
- acetic acid esters examples include acetic acid esters, carboxylic acid esters such as benzoic acid esters, sulfate esters, etc.
- alkyl ethers eg, ethers with alkyl having 8 to 25 carbon atoms
- halides nitrogen-containing derivatives, sulfur-containing derivatives and the like.
- Trehalose and its derivatives are commercially available, but may be produced by known methods! The method of preparing trehalose and its derivatives is as follows:
- 10 5 - 10 ⁇ preferably 10 4 - 10-protecting agents may be added Caro to mixed-.
- the support may further have an enzyme reaction promoter immobilized thereon.
- the enzyme reaction accelerator is a substance that has the effect of promoting the enzyme reaction, the effect of promoting the enzyme reaction includes the effect of suppressing the inhibition of the enzyme reaction.
- the enzyme reaction accelerator include sodium oxalate, potassium oxalate, sodium masonate, sodium maleate, dimethyl sulfoxide, betaine, glycerol, albumin, and surfactants (for example, tween20, Triton X100, NP40, etc.).
- Polyamines eg, ethylenediamine, trimethylenediamine, spermine, spermidine, diethylenetriamine, triethylenetetramine, tetraethylenepentamine, pentaethylenehexamine, 1,4-bis (3-aminopropyl) -piperazine, 1— ( 2-aminoethyl) pirazine, 1- (2-aminoethyl) piperidine, 1,4,10,13-tetraoxa-1,16-diazacyclooctadecane and tris (2-aminoethyl) amine ), Sugars (eg, glucose, fructose, galactose) , Maltose, sucrose, ratatose, and other polysaccharides), sulfated polysaccharides and their salts (eg, heparin, dextran sulfate, etc.), dithiothreitol, polyaone (eg, DNA, RNA, etc.
- Amide, hexafluorenium bromide, methyl azolidium bromide, etc. examples include Ampdirect (R) (manufactured by Shimadzu Corporation) and the like, which is effective for promoting the reaction of DNA polymerase.
- the enzyme reaction promoter supports an appropriate amount of the enzyme reaction promoter so that, for example, in the case of a polyamine, the enzyme reaction accelerator is present at about 10 to 0.5 OlmM, preferably 2 to 0.5 mM. It should be fixed to the body.
- the enzyme reaction accelerator is the same as the mixture of the enzyme and the protective agent. It may be immobilized on the support, or may be immobilized on the support at a different position from the enzyme and the protective agent.
- the support may be any as long as it can fix a mixture of an enzyme and a protective agent.
- the support include paper (for example, 60MDP paper (manufactured by Mishima Paper), copy paper, high-quality paper, Medium paper, Kent paper, drawing paper, kraft paper, inkjet paper, tracing paper, Japanese paper, cardboard, filter paper, etc.), glass substrate, silicon substrate, beads, column filler, silica gel, nitrocellulose membrane, nylon membrane, PVA A force that can exemplify a film or the like is not limited to these.
- the thickness of the support may be, for example, 1 mm or less. If the thickness is made extremely thin (for example, about 0.1 mm), the workability is improved even when a large number of supports on which enzymes and protective agents are fixed are stacked and distributed.
- the support includes, in addition to enzymes and protective agents, polynucleotides (eg, DNA, RNA, their derivatives, modified products, etc.) and oligonucleotides (eg, DNA, RNA, their derivatives, modified products, etc.) , Proteins (eg, antibodies, hormones, etc.), polypeptides, oligopeptides, polysaccharides, oligosaccharides, PNA, low molecular weight compounds (eg, EDTA, salts contained in PCR buffer compositions, Mg 2+ , dNTP mixtures, etc.) ), Mixtures thereof and the like may be fixed.
- polynucleotides eg, DNA, RNA, their derivatives, modified products, etc.
- oligonucleotides eg, DNA, RNA, their derivatives, modified products, etc.
- Proteins eg, antibodies, hormones, etc.
- polypeptides eg, oligopeptides
- Components other than the enzyme and the protective agent may be fixed on the support at the same position as the mixture of the enzyme and the protective agent, or may be fixed to the support at a position different from the enzyme and the protective agent.
- the present invention which claims that an abtamer for an enzyme is immobilized on a support, also provides a support on which an enzyme and an abtamer for the enzyme are immobilized.
- a support is a primer for amplifying a target nucleic acid in a nucleic acid amplification reaction using the DNA polymerase, in addition to the DNA polymerase and the protecting agent for the DNA polymerase. including.
- a support can be used for genotyping and species identification.
- the support may further include an accelerator for the enzymatic reaction.
- the support in addition to the DNA polymerase and the protective agent for the DNA polymerase, may be a nucleic acid that is a type II nucleic acid amplification reaction (eg, PCR) using the DNA polymerase. , A primer for amplifying the nucleic acid, and a nucleic acid amplification reaction A buffer for the at least one that is selected.
- the support may further include an enzyme reaction promoter.
- the paper when a DNA polymerase is fixed and stored on paper (support), the paper contains, in addition to the DNA polymerase and the protective agent, a primer set (oligonucleotide), (Synthetic single-stranded or double-stranded DNA may be used, or a vector obtained by closing cDNA).
- a primer set oligonucleotide
- Abtamer for DNA polymerase functional RNA
- Each component in PCR reaction solution ie, Tris-HCU KC1 , MgCl, dNTP mixture, etc.
- EDTA and the like may be immobilized.
- DNA, Tris-HCl and EDTA which will be the type II of the PCR reaction, may be immobilized on paper as separate spots with DNA polymerase, protective agent and primer set as one spot, or (2) ) DNA polymerase, protecting agent and primer set, if necessary, aptamer for DNA polymerase may be fixed as one spot on paper, or (3) all components necessary for PCR reaction (i.e. If necessary, the DNA polymerase, primer set, Tris-HCU KC1, MgCl, dNTP mixture, etc. may be immobilized on a piece of paper together with a protecting agent as one spot, if necessary.
- a dye to the components to be spotted so that it can be seen that components such as DNA polymerase are spotted on the paper.
- the dye include, but are not limited to, cresol red, bromophenol blue, xylenesanol, and the like.
- the amount of the enzyme immobilized on the support may be appropriately adjusted so that a desired enzyme reaction is performed. For example, in order to perform a PCR reaction, it is preferable that 5 ng or more of DNA polymerase is fixed per spot.
- a support on which a mixture of an enzyme and a protective agent for the enzyme is immobilized can be produced as follows. First, a mixed solution of an enzyme and a protective agent is prepared. The mixing ratio of the enzyme and the protective agent is as described above. The solvent may be water. Further, the above-mentioned components other than the enzyme and the protective agent may be added to this mixed solution. Next, a mixed solution of the enzyme and the protecting agent is applied to the support. For example, when the support is paper, a mixed solution is used using a dropper, a 96 pin-tool (Multi 96-multiblot replicator VP409, Bio Medical Science Inc., US), a taste-possible type pin-tool, or the like. Can be spotted on paper it can. Thereafter, the mixture of the enzyme and the protective agent is immobilized on the support by drying the support. The support on which the mixture of the enzyme and the protective agent is immobilized should be substantially free of water.
- the enzyme can be stably stored by fixing the enzyme to the support as a mixture with the protective agent.
- As storage conditions it is preferable to store at room temperature, avoiding high humidity, and shielded from light.
- the enzyme is a DNA polymerase
- a shelf life of at least 6 and a half months has been confirmed when the DNA polymerase is stored as a mixture with trehalose on 60MDP paper at room temperature. Is ongoing).
- the support immobilized with the mixture of the enzyme and the protective agent is immersed in a liquid, and the enzyme is immersed in the liquid. May be eluted.
- the liquid in which the support is immersed may be any liquid as long as it can regenerate the enzyme, and examples thereof include water and an aqueous solution containing components other than water.
- the present invention is not limited to these.
- the enzyme immobilized on the support is DNA polymerase
- the liquid in which the support is immersed is water, a PCR reaction solution (i.e., an aqueous solution containing Tris-HCU KC1, MgCl, dNTP mixture, etc.). Good.
- the immersion may be performed at room temperature under atmospheric pressure for 13 minutes.
- the DNA polymerase When a DNA polymerase is immobilized on a support, the DNA polymerase is eluted from the support by disposing the support in a liquid, and a nucleic acid amplification reaction is performed using the DNA polymerase. Thereby, the nucleic acid can be amplified.
- the present invention also provides a printed material including a support on which an enzyme and a protective agent for the enzyme are immobilized.
- Printed materials include textbooks and other books, handbooks, catalogs, periodicals, magazines, dissertations, booklets, booklets, leaflets, pamphlets, reports, posters, cards, labels, and the like. However, it is not limited to these.
- FIG. 1 shows an example of paper (support) on which a mixture of an enzyme (DNA polymerase) and trehalose is spotted in the printed matter of the present invention.
- DNA polymerase and trehalose contain primer sets, cDNA Components (ie, Tris-HCU KC1, MgCl, each dNTP, and if necessary, an aptamer for DNA polymerase) are spotted (hereinafter, this spot is referred to as “DNA SpotJ 1”).
- paper 6 contains the name of the protein encoded by the cDNA clone (such as malate dehydrogenase), the identification number of the cDNA clone (Clone ID), and the nucleotide sequence of the cDNA clone (DNA sequence). ), Explanation 5 (Procedures) of the procedure of the experiment (PCR reaction) is printed!
- FIG. 2 shows a journal 13 in which an academic paper 12 with the paper 6 having the DNA spot 1 shown in FIG. 1 attached as a separate paper is published.
- FIG. 3 shows a book 22 in which the paper 6 having the DNA spot 1 shown in FIG. 1 is bound.
- the book should also include a table of contents.
- Fig. 4 shows another embodiment of a book in which a mixture of an enzyme (DNA polymerase) and trehalose is spotted and bound with V-paper (support).
- DNA polymerase an enzyme
- trehalose On each grid on page 34 where a mixture of enzyme (DNA polymerase) and trehalose is spotted, DNA polymerase and trehalose are required for primer sets, cDNA clones that are the type II PCR reaction, and other PCR reactions.
- These components are spotted together with various components (ie, Tris-HCU KC1, MgCl, each dNTP, and, if necessary, an aptamer for DNA polymerase) (hereinafter, this spot is referred to as “DNA Spot” 31).
- a symbol (column number) 32 and (row number) 33 for identifying the spot are printed on the page 34 having the spot 31, a symbol (column number) 32 and (row number) 33 for identifying the spot are printed.
- the identification number 30 (Rearray PLATE ID) of the page where the DNA was spotted is printed.
- Information on the spotted cDNA clone eg, EC number of the enzyme encoded by the cDNA clone, name of the enzyme encoded by the cDNA clone (Gene name), ID number of the clone (RIKEN Clone ID), deposit number ( Accesion Number), cDNA clone insert length (cDNA Insert), PCR reaction product length (After PCR), description of reactions involving enzymes encoded by cDNA clones, etc.
- primer sets e.g., The primer sequences, etc.
- CD-ROM36 which may be a medium such as FD or MO instead of CD-ROM
- the CD-ROM 36 is put in a bag 37 and attached to a book 35 in a state where it is sealed with a seal 38.
- the book also includes a table of contents, cDNA clones and primers. Instructions on how to use the spot including the merset and how to access the information recorded on the recording medium are printed and include a page.
- the forms of the printed matter include: 1) a comprehensive encyclopedia type (for example, FANTOM clone, human metabolome, etc.), 2) a separate volume for each field (for example, by function or organ, etc.), 3) Themes can be further exemplified by themes or the content of each page can be divided into several pages (for example, loose-leaf type), and 4) Card types that are intended for a smaller number of pasted items.
- a comprehensive encyclopedia type for example, FANTOM clone, human metabolome, etc.
- a separate volume for each field for example, by function or organ, etc.
- Themes can be further exemplified by themes or the content of each page can be divided into several pages (for example, loose-leaf type), and 4) Card types that are intended for a smaller number of pasted items.
- the present invention provides a reagent kit including a support on which an enzyme and a protective agent for the enzyme are immobilized.
- the reagent kit of the present invention can be used for various experiments, tests, diagnoses, and the like as a nucleic acid amplification reaction (eg, PCR) kit, a protein generation kit, an antibody kit, and other kits.
- a nucleic acid amplification reaction eg, PCR
- the reagent kit of the present invention may take the form of a printed material as described above, but examples of other forms are shown in FIGS. 6-9.
- FIG. 6 shows an example of paper (support) on which a mixture of an enzyme (DNA polymerase) and trehalose is spotted in the reagent kit of the present invention.
- This paper shows that DNA polymerase and trehalose contain primer sets and other components necessary for the PCR reaction (that is, Tris-HC1, KC1, MgCl, dNTPs, and, if necessary, an aptamer for DNA polymerase).
- primer sets and other components necessary for the PCR reaction that is, Tris-HC1, KC1, MgCl, dNTPs, and, if necessary, an aptamer for DNA polymerase.
- this spot is spotted at an appropriate position on the paper (hereinafter, this spot is referred to as “DNA spot” 41).
- FIG. 7 shows an example of a reagent kit including the paper 42 having the DNA spot 41 shown in FIG.
- the paper 42 having the DNA spots 41 is put in a light-shielding bottle 51, sealed with a lid 52, and stored or distributed.
- Reagent kits also include the contents of the kit (eg, components included in the kit-amount, purpose of use, storage method, expiration date, packaging unit, etc.), instructions for use, precautions for use and handling, contact information, etc. It should include a description 53 with information on:
- the instructions 53 may be placed in the light-shielding bottle 51 or in a packaging box (not shown) in which the light-shielding bottle 51 is placed.
- an instruction may be printed on a label, and the label may be attached to the light shielding bin 51.
- FIG. 8 shows the relationship between the enzyme (DNA polymerase) and trehalose in the reagent kit of the present invention.
- 1 shows an example of a paper (support) on which a mixture is spotted.
- This paper 62 contains the DNA polymerase and trehalose together with the primer set and other components required for the PCR reaction (ie, Tris-HCU KC1, MgCl, each dNTP, and, if necessary, the aptamer for DNA polymerase).
- This spot is referred to as “DNA Spot” 61 below.
- FIG. 9 shows an example of a reagent kit including a paper 62 having a DNA Spot 61.
- the paper 62 having the DNA spot 61 is placed in a packaging pack 71 and stored or distributed in a sealed state.
- Reagent kits also include the kit contents (eg, components included in the kit, intended use, storage method, expiration date, packaging unit, etc.), instructions for use, precautions for use and handling, and inquiries. It should include a description 72 with information such as the information.
- the instructions 72 may be placed in the packaging pack 71, or may be placed in a packaging box (not shown) containing the packaging pack 71. Alternatively, the instruction manual 72 may be printed on a label, and the label may be attached to the packaging pack 71 or the packaging box.
- the present invention has been described with respect to an embodiment in which a DNA polymerase is combined with DNA.
- the present invention is not limited to this embodiment, and can be applied to various enzymes.
- one indicates a range including numerical values described before and after it as a minimum value and a maximum value, respectively.
- the present invention has provided a simple method for storing an enzyme.
- FIG. 1 shows an example of paper (support) in which a mixture of DNA polymerase and trehalose is spotted together with DNA (cDNA, primers, aptamers, etc.).
- FIG. 2 This shows a journal that contains an academic paper attached with a paper in which a mixture of DNA polymerase and trehalose is spotted with DNA (cDNA, primers, aptamers, etc.) as a separate sheet.
- cDNA, primer, 1 shows an example of a book in which paper spotted together with a marker is bound.
- FIG. 4 shows another embodiment of a book in which a mixture of DNA polymerase and trehalose is spotted with DNA (cDNA, primers, aptamers, etc.) and bound with a paper (support).
- FIG. 5 This shows a form in which a CD-ROM in which information on cDNA spotted on the paper of FIG. 4 is recorded is put in a bag, attached to a book in a state of being sealed with a seal, and the like.
- FIG. 6 shows an example of paper (support) in which a mixture of DNA polymerase and trehalose is spotted with DNA (cDNA, primers, aptamers, etc.).
- FIG. 7 shows an example of a reagent kit including the paper of FIG.
- FIG. 8 shows an example of paper (support) in which a mixture of DNA polymerase and trehalose is spotted with DNA (cDNA, primers, aptamers, etc.).
- FIG. 9 shows an example of a reagent kit including the paper of FIG.
- FIG. 10 shows the construction of a pFLC vector in which mouse malate dehydrogenase cDNA was cloned.
- FIG. 11 shows a 60 MDP paper having a spot of a cDNA solution of mouse malate dehydrogenase and a spot of a single solution of polymerase and primer.
- FIG. 12 shows the results of electrophoresis of a reaction product of a PCR reaction performed using the spots in FIG.
- FIG. 13 shows a 60MDP paper having a spot of primer + aptamer + polymerase solution.
- FIG. 14 shows the results of electrophoresis of a reaction product of a PCR reaction performed using the spots of FIG.
- FIG. 15 cDNA of mouse malate dehydrogenase, mouse isoquenate dehydrogenase (NADP), mouse disoquate dehydrogenase (NAD) or mouse oxoglutarate dehydrogenase + primer + aptamer + polymerase + Shown is a 60MDP paper having a spot of a buffer composition solution for PCR.
- NADP mouse isoquenate dehydrogenase
- NAD mouse disoquate dehydrogenase
- primer + aptamer + polymerase + Shown is a 60MDP paper having a spot of a buffer composition solution for PCR.
- FIG. 16 The results of electrophoresis of the reaction product of the PCR reaction performed using the spots in FIG. Show.
- FIG. 17 shows the results of electrophoresis of a reaction product of a PCR reaction performed using spots of cDNA + primer + reaction accelerator (spermidine) + polymerase + PCR buffer composition solution.
- a primer set having the following sequence was synthesized by a conventional method.
- PFLC vector (clone ID: 1500012M15, 1758 bp) cloned from the mouse malate dehydrogenase cDNA represented by the following nucleotide sequence from the RIKEN clone (http: @ fantom.gs riken.go.jp/) Figure 10) was dissolved in TE (10 mM Tris-HCl (pH 8.0), 1 mM EDTA) to a concentration of 0.1 g / 1.
- the cDNA solution and polymerase + primer solution prepared on 60MDP paper were spotted using a 96-pin-tool (Multi 96-multiblot replicator VP409, Bio Medical Science Inc., US) as shown in Fig. 11. Was spotted so that the position and type of the can be determined.
- the cDNA solution was adjusted to 0.5 / zlZ spot and the polymerase + primer solution was adjusted to 11 1 spot.
- 60MDP paper was cut to a size of 4 mm x 4 mm to contain the spotted cDNA and polymerase + primer, and placed in a PCR microtube. 25 ⁇ l of a PCR reaction solution (10 mM Tris-HCl (pH 8.3), 50 mM KC1, 5.3 mM MgCl, 200 ⁇ M each dNTP) was added to the tube, and PCR was performed under the following conditions.
- a PCR reaction solution (10 mM Tris-HCl (pH 8.3), 50 mM KC1, 5.3 mM MgCl, 200 ⁇ M each dNTP
- Fig. 12 shows the results of electrophoresis on a 1% agarose gel after taking an appropriate amount from the tube after the reaction.
- the band seen around 1800 bp was considered to be the target fragment, and DNA was eluted from the 60MDP paper, indicating that the DNA could be amplified by PCR.
- Primer set 1 (Primer set for amplifying human luteinizing hormone gene exon 1) HsLHIF: CCAGGGGCTGCTGCTGTTG (SEQ ID NO: 4)
- HsLH 1 R CATGGTGGGGCAGTAGCC (SEQ ID NO: 5)
- Primer set 2 (primer set for amplifying human luteinizing hormone gene exon 2)
- HsLH2F ATGCGCGTGCTGCAGGCG (SEQ ID NO: 6)
- HsLH2R TGCGGATTGAGAAGCCTTTATTG (SEQ ID NO: 7)
- Oligonucleotides having the following sequences, which are Jayasena Inhibition of Multiple Thermostable DNA Polymerases by a Heterodimenc Aptamer Journal of Molecular Biology (1997), Vol. 27, Issue 1, pages 100-11), were synthesized by a conventional method.
- the primer + abtamer + polymerase solution prepared above was applied to 60MDP paper (manufactured by Mishima Paper) using a 96 pin-tool (Multi 96-multiblot replicator VP409, Bio Medical Science Inc., US) as shown in Fig. 13. , Spots were spotted so that the position and type of spot could be determined. The spotting solution was made to be 11Z spot.
- PCR reaction solution (10 mM Tris-HCl (pH 8.3), 50 mM KC1, 5.3 mM MgCl, 200 ⁇ M each dNTP) 25 1 and 50 ng template DNA (human genomic DNA, BD Biosciences Clontech, US)
- PCR was performed under the following conditions.
- Figure 14 shows the results of electrophoresis on a 1% agarose gel after taking an appropriate amount from the tube after the reaction.
- the bands seen around 184 bp and 343 bp are considered to be the target DNA fragments of exons 1 and 2, respectively.
- the target fragments should be able to amplify the target fragments by PCR using template DNA immobilized primers on 60MDP paper. I understood.
- comparing the presence or absence of an aptamer to Taq DNA polymerase it was found that the reaction including the aptamer can suppress non-specific amplification.
- a primer set having the following sequence was synthesized by a conventional method.
- Mouse malate dehydrogenase cDNA (clone ID: 1500012M15, 1758 bp) represented by the following nucleotide sequence from the RIKEN clone (http: @ fantom.gs riken.go.jp/), mouse isogenate dehydrogenation Cloning enzyme (NADP) (clone ID: 1500012E04, 2440bp), mouse isoquenate dehydrogenase (NAD) (clone ID: E030024J03, 2160bp), mouse oxoglutarate dehydrogenase (clone ID: E430020N12, 3554bp)
- NADP mouse isogenate dehydrogenation Cloning enzyme
- NAD mouse isoquenate dehydrogenase
- E430020N12, 3554bp mouse oxoglutarate dehydrogenase
- the obtained pFLC vector (FIG. 10) was dissolved in TE (10 mM Tri
- NADP Mouse isoquenate dehydrogenase
- cDNA + primer + aptamer + polymerase + PCR buffer Above cDNA, primer set 1, aptamer for Taq DNA polymerase, and Taq DNA polymearse, final concentration, 5 ⁇ primer set 1, 5 ⁇ M aptamer for Taq DNA polymerase, 50 U / 1 Taq DNA polymerase, 0.1 M trehalose , 250 mM Tris-HCl (pH 8.3), 1.25 M KC1, 132.5 mM MgCl, and 5 ⁇ M dNTP.
- PCR was performed under the following conditions.
- Figure 16 shows the results of electrophoresis on a 1% agarose gel after taking an appropriate amount from the tube after the reaction.
- Lane 1 is the malate dehydrogenase cDNA
- Lane 2 is the isoenzyne dehydrogenase (NADP) cDNA
- Lane 3 is the isoquensan dehydrogenase (NAD) cDNA
- Lane 4 is the oxoglutarate dehydrogenase cDNA
- the left end shows a size marker. Fragments of the desired length were obtained for each of the four cDNAs, and PCR amplification was performed by adding only water to the cDNA, primers, aptamers, polymerase, and PCR buffer composition fixed on 60MDP paper. It turned out to be possible.
- a pFLC vector (FIG. 10) in which the same mouse malate dehydrogenase cDNA clone (clone ID: 1500012M15, 1758 bp) used in Example 3 was cloned into TE (10 mM Tris- HCl (pH 8.0), 1 mM EDTA).
- cDNA 0.005 ⁇ g / ⁇ ⁇ , 5 ⁇ primer set, 50 U / ⁇ 1 Taq DNA polymerase, supermidine 100 mM, 0.1 M trehalose, 250 mM Tris-HCl (pH 8.3), 1.25 M KC1, 132.5 mM MgCl, and 5 M were adjusted to each dNTP.
- PCR was performed under the following conditions.
- Lane 17 shows the results.
- Lanes 1 and 2 are samples in which cDNA, primers, polymerase, spermidine, a type of polyamine as a reaction promoter, and a PCR buffer composition were immobilized on 60MDP paper.
- Lane3 is a sample in which the composition excluding spermidine alone is fixed. In both cases, it was found that the immobilized DNA can be amplified by adding water, and the amplification reaction was accelerated in the sample in which the reaction accelerator was immobilized.
- the support of the present invention can be used for storage and distribution of enzymes. It can also be applied to printed materials and reagent kits.
- SEQ ID NO: 1 shows the nucleotide sequence of Primer-21M13.
- SEQ ID NO: 2 shows the nucleotide sequence of primer 1233-Rv.
- SEQ ID NO: 3 shows the nucleotide sequence of mouse malate dehydrogenase cDNA.
- SEQ ID NO: 4 shows the nucleotide sequence of primer HsLHIF.
- SEQ ID NO: 5 shows the nucleotide sequence of primer HsLHIR.
- SEQ ID NO: 6 shows the nucleotide sequence of primer HsLH2F.
- SEQ ID NO: 7 shows the nucleotide sequence of primer HsLH2R.
- SEQ ID NO: 8 shows the nucleotide sequence of aptamer for Taq DNA polymerase.
- SEQ ID NO: 9 shows the nucleotide sequence of mouse isoquinate dehydrogenase (NADP) cDNA.
- SEQ ID NO: 10 shows the nucleotide sequence of mouse isoquenate dehydrogenase (NAD) cDNA.
- SEQ ID NO: 11 2 shows the nucleotide sequence of the cDNA of oxodaltalate dehydrogenase.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005514250A JPWO2005030958A1 (ja) | 2003-09-30 | 2004-09-29 | 酵素が固定されている支持体、印刷物、試薬キット、該支持体の製造法、酵素の保存法及び酵素の再生法 |
EP04788311A EP1674569A1 (en) | 2003-09-30 | 2004-09-29 | Support having enzyme immobilized thereon, print, reagent kit, process for producing the support, method of preserving enzyme and method of revitalizing enzyme |
US10/574,165 US20070117094A1 (en) | 2003-09-30 | 2004-09-29 | Support, printed material and reagent kit having enzyme fixed thereon, method for preparing the support, method of storing enzyme and method for restoration enzymes |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003-339542 | 2003-09-30 | ||
JP2003339542 | 2003-09-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005030958A1 true WO2005030958A1 (ja) | 2005-04-07 |
Family
ID=34386182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/014245 WO2005030958A1 (ja) | 2003-09-30 | 2004-09-29 | 酵素が固定されている支持体、印刷物、試薬キット、該支持体の製造法、酵素の保存法及び酵素の再生法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20070117094A1 (ja) |
EP (1) | EP1674569A1 (ja) |
JP (1) | JPWO2005030958A1 (ja) |
WO (1) | WO2005030958A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009107816A1 (ja) * | 2008-02-29 | 2009-09-03 | 独立行政法人理化学研究所 | 酵素の反応性を改善する方法 |
JP2010142229A (ja) * | 2008-12-19 | 2010-07-01 | F Hoffmann La Roche Ag | 反応化合物と安定化ポリメラーゼの乾燥組成物 |
JP2010233505A (ja) * | 2009-03-31 | 2010-10-21 | Toyobo Co Ltd | 保存安定性に優れた核酸増幅検出試薬キット |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006090987A1 (en) * | 2005-02-28 | 2006-08-31 | Bioquest, Inc. | Methods for performing direct enzymatic reactions involving nucleic acid molecules |
JP5384313B2 (ja) * | 2008-12-24 | 2014-01-08 | 日本碍子株式会社 | 複合基板の製造方法及び複合基板 |
EP2694670B1 (en) * | 2011-04-08 | 2017-07-19 | Bio-Rad Laboratories, Inc. | Pcr reaction mixtures with decreased non-specific activity |
WO2015085209A1 (en) * | 2013-12-06 | 2015-06-11 | President And Fellows Of Harvard College | Paper-based synthetic gene networks |
US10689629B1 (en) | 2017-12-06 | 2020-06-23 | Cepheid | Inhibition of nucleic acid polymerases by endonuclease V-cleavable circular oligonucleotide ligands |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10503383A (ja) * | 1995-02-10 | 1998-03-31 | ジェン−プローブ・インコーポレーテッド | 核酸増幅用の安定化された酵素組成物 |
JP2000514298A (ja) * | 1996-07-16 | 2000-10-31 | インヴィテック ゲーエムベーハー | コンプレックス多酵素貯蔵安定性反応混合物の製造方法とその使用方法 |
JP2003519482A (ja) * | 2000-01-10 | 2003-06-24 | ワットマン インコーポレイテッド | 核酸を保存および合成する方法 |
-
2004
- 2004-09-29 JP JP2005514250A patent/JPWO2005030958A1/ja active Pending
- 2004-09-29 WO PCT/JP2004/014245 patent/WO2005030958A1/ja active Application Filing
- 2004-09-29 EP EP04788311A patent/EP1674569A1/en not_active Withdrawn
- 2004-09-29 US US10/574,165 patent/US20070117094A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10503383A (ja) * | 1995-02-10 | 1998-03-31 | ジェン−プローブ・インコーポレーテッド | 核酸増幅用の安定化された酵素組成物 |
JP2000514298A (ja) * | 1996-07-16 | 2000-10-31 | インヴィテック ゲーエムベーハー | コンプレックス多酵素貯蔵安定性反応混合物の製造方法とその使用方法 |
JP2003519482A (ja) * | 2000-01-10 | 2003-06-24 | ワットマン インコーポレイテッド | 核酸を保存および合成する方法 |
Non-Patent Citations (3)
Title |
---|
KAWAI J. ET AL.: "DNA book", GENOME RES., vol. 13, no. 6B, June 2003 (2003-06-01), pages 1488 - 1495, XP002983464 * |
LIN Y. ET AL.: "Inhibition of multiple thermostable DNA polymerases by a heterodimetric aptamer", J. MOL. BIOL., vol. 271, no. 1, 1997, pages 100 - 111, XP004455903 * |
WAN C.Y. ET AL.: "Spermidine facilitates PCR amplification of target DNA", PCR METHODS APPL., vol. 3, no. 3, 1993, pages 208 - 210, XP002149056 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009107816A1 (ja) * | 2008-02-29 | 2009-09-03 | 独立行政法人理化学研究所 | 酵素の反応性を改善する方法 |
JP5515121B2 (ja) * | 2008-02-29 | 2014-06-11 | 独立行政法人理化学研究所 | 酵素の反応性を改善する方法 |
JP2010142229A (ja) * | 2008-12-19 | 2010-07-01 | F Hoffmann La Roche Ag | 反応化合物と安定化ポリメラーゼの乾燥組成物 |
JP2015091261A (ja) * | 2008-12-19 | 2015-05-14 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 反応化合物と安定化ポリメラーゼの乾燥組成物 |
JP2010233505A (ja) * | 2009-03-31 | 2010-10-21 | Toyobo Co Ltd | 保存安定性に優れた核酸増幅検出試薬キット |
Also Published As
Publication number | Publication date |
---|---|
EP1674569A1 (en) | 2006-06-28 |
JPWO2005030958A1 (ja) | 2007-11-15 |
US20070117094A1 (en) | 2007-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pereira et al. | Kinetic studies of lipase from Candida rugosa: a comparative study between free and immobilized enzyme onto porous chitosan beads | |
US10160997B2 (en) | Matrices and media for storage and stabilization of biomolecules | |
Brena et al. | Immobilization of enzymes: a literature survey | |
Yi et al. | Covalent immobilization of ω-transaminase from Vibrio fluvialis JS17 on chitosan beads | |
Pessela et al. | Reversible immobilization of a thermophilic β-galactosidase via ionic adsorption on PEI-coated Sepabeads | |
JP7105307B2 (ja) | トランスアミナーゼ突然変異体及びその応用 | |
Guisan | New opportunities for immobilization of enzymes | |
WO2005030958A1 (ja) | 酵素が固定されている支持体、印刷物、試薬キット、該支持体の製造法、酵素の保存法及び酵素の再生法 | |
US20200354770A1 (en) | Cation chelator hot start | |
BR112016017398B1 (pt) | Material de enzima imobilizado, uso de um carreador, e, métodos para preparação de um material de enzima imobilizado e para catalisação de uma reação | |
Haque et al. | Haloferax volcanii as immobilised whole cell biocatalyst: new applications for halophilic systems | |
Morellon-Sterling et al. | Effect of amine length in the interference of the multipoint covalent immobilization of enzymes on glyoxyl agarose beads | |
Pessela et al. | Stabilization of a Multimeric β‐Galactosidase from Thermus sp. Strain T2 by Immobilization on Novel Heterofunctional Epoxy Supports Plus Aldehyde‐Dextran Cross‐Linking | |
Bryjak et al. | Evaluation of man-tailored cellulose-based carriers in glucoamylase immobilization | |
Fuentes et al. | New cationic exchanger support for reversible immobilization of proteins | |
Reddy et al. | Immobilized nucleases | |
Chen et al. | Efficient immobilization of whole cells of Methylomonas sp. strain GYJ3 by sol–gel entrapment | |
Mateo et al. | Very strong but reversible immobilization of enzymes on supports coated with ionic polymers | |
Toogood et al. | Immobilisation of the thermostable L-aminoacylase from Thermococcus litoralis to generate a reusable industrial biocatalyst | |
Peper et al. | Immobilization and characterization of benzoylformate decarboxylase from Pseudomonas putida on spherical silica carrier | |
Mateo et al. | Very strong but reversible immobilization of enzymes on supports coated with ionic polymers | |
Bayramoğlu et al. | Immobilization of Candida rugosa lipase onto spacer-arm attached poly (GMA-HEMA-EGDMA) microspheres | |
US20230086755A1 (en) | Reagent compositions, methods, cartridges, and systems | |
ES2352779B1 (es) | Complejos covalentes de lipasas con proteinas, sondas de adn, cofactores u otras biomoleculas | |
Bircakova et al. | Oriented immobilization of restriction endonuclease ecori |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005514250 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004788311 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004788311 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007117094 Country of ref document: US Ref document number: 10574165 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10574165 Country of ref document: US |